The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Abstract
Summary: The importance of inflammation as a driver of pathology is no longer confined to autoimmune and infectious diseases. In line with convincing experimental data as well as abundant clinical findings the current view of atherosclerosis points to inflammation as a critical regulator of atherosclerotic plaque formation and progression leading to the fatal clinical endpoints myocardial infarction, stroke or sudden cardiac death. The underlying mechanisms have been a matter of intense research during the last decades. In this regard, the interleukin-6 (IL-6) cytokines and their signalling events have been shown to contribute to both, atherosclerotic plaque development and plaque destabilisation via a variety of mechanisms. These involve the release of other pro-inflammatory cytokines, oxidation of lipoproteins by phospholipases, stimulation of acute phase protein secretion, the release of prothrombotic mediators, and the activation of matrix metalloproteinases. Moreover, the formation of reactive oxygen species generated by vascular enzyme systems may play a critical role in the regulation of IL-6 indicating a cross talk between vasoactive substances i.e. angiotensin II or adrenalin and pro-inflammatory cytokines such as IL-6. In this review we will summarise and discuss the underlying molecular and cellular mechanisms how IL-6 as an early and central regulator of inflammation contributes to atherosclerosis and how this knowledge can be integrated into the clinical context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“It is responsible for the induction of cytotoxic T-lymphocyte differentiation (53) and comprises a key regulatory signal in the development of Th17-cells while concomitantly blocking the differentiation of CD4+ cells into T-regulatory cells (54).”
BackgroundRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Serum amyloid A, the major vertebrate acute‐phase reactant
Uhlar, C. M., & Whitehead, A. S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00657.x · Cited by 1,106
Acute phase reaction and acute phase proteins
Gruys, E., Toussaint, M. J. M., Niewold, T. A., & Koopmans, S. J. (2005) · Journal of Zhejiang University-SCIENCE B · doi:10.1631/jzus.2005.b1045 · Cited by 1,080
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Venugopal, S. K., Devaraj, S., Yuhanna, I., Shaul, P., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 853
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Ikebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y., & Ogawa, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9035 · Cited by 802
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Weber, C., Zernecke, A., & Libby, P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2415 · Cited by 776
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754
Pradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., & Ridker, P. M. (2002) · JAMA · doi:10.1001/jama.288.8.980 · Cited by 680
Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.914 · Cited by 669
Gibbons, G. H., Pratt, R. E., & Dzau, V. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115881 · Cited by 645
Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion
Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Obesity Research · doi:10.1038/oby.2001.54 · Cited by 639
Naftilan, A. J., Pratt, R. E., & Dzau, V. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114032 · Cited by 623
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604
Lindmark, E., Diderholm, E., Wallentin, L., & Siegbahn, A. (2001) · JAMA · doi:10.1001/jama.286.17.2107 · Cited by 556
Endothelial Function and Oxidative Stress in Renovascular Hypertension
Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T., & Chayama, K. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013591 · Cited by 544
Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 530
The role of the renin-angiotensin system in the development of cardiovascular disease
Unger, T. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02321-9 · Cited by 515
Exercise as a Mean to Control Low‐Grade Systemic Inflammation
Mathur, N., & Pedersen, B. K. (2008) · Mediators of Inflammation · doi:10.1155/2008/109502 · Cited by 514 · cited 1×
“On the other hand IL-6 is also rapidly secreted from the working skeletal muscle thereby ensuring the short-term energy supply of the muscle cells and contributing to the anti-inflammatory properties of temporary IL-6 secretion (26, 27).”
BackgroundHernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
Miles, S. A., Rezai, A. R., Salazar-González, J. F., Vander Meyden, M., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., & Kishimoto, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4068 · Cited by 475
Le, J., & Vilček, J. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_7 · Cited by 474
Itoh, H., Mukoyama, M., Pratt, R. E., Gibbons, G. H., & Dzau, V. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116454 · Cited by 469
Wassmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Böhm, M., & Nickenig, G. (2004) · Circulation Research · doi:10.1161/01.res.0000115557.25127.8d · Cited by 468
Self-citationInterleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6.
Satoh, T., Nakamura, S., Taga, T., Matsuda, T., Hirano, T., Kishimoto, T., & Kaziro, Y. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3546 · Cited by 414
Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomas
Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., & Kishimoto, T. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80805-1 · Cited by 411
Involvement of IL-6 in mesangial proliferative glomerulonephritis.
Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.3949 · Cited by 408
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi, T., Kimura, H., Uchida, T., Kariyone, S., Friese, P., & Burstein, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5953 · Cited by 407
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390 · cited 1×
“Besides the membrane-bound IL-6R, a soluble form (sIL-6R) can be generated by proteolytic cleavage by ADAM17 (11, 12) or alternative splicing (13).”
BackgroundA Tale of Two Diseases: Atherosclerosis and Rheumatoid Arthritis
Pasceri, V., & Yeh, E. T. H. (1999) · Circulation · doi:10.1161/01.cir.100.21.2124 · Cited by 377
Inflammation in Atherosclerosis and Implications for Therapy
Paoletti, R., Gotto, A. M., & Hajjar, D. P. (2004) · Circulation · doi:10.1161/01.cir.0000131514.71167.2e · Cited by 349
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation
McLoughlin, R. M., Jenkins, B. J., Grail, D., Williams, A. S., Fielding, C. A., Parker, C. R., Ernst, M., Topley, N., & Jones, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501794102 · Cited by 333
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 332
Dose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324
Kerins, D. M., Hao, Q., & Vaughan, D. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118312 · Cited by 304
Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., & Haegeman, G. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00412-3 · Cited by 303
Sano, M., Fukuda, K., Sato, T., Kawaguchi, H., Suematsu, M., Matsuda, S., Koyasu, S., Matsui, H., Yamauchi-Takihara, K., Harada, M., et al. (2001) · Circulation Research · doi:10.1161/hh2001.098873 · Cited by 298
Atherosclerosis and Oxidative Stress
Yamada, N. (2001) · Cited by 296
Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis
Schieffer, B., Selle, T., Hilfiker, A., Hilfiker-Kleiner, D., Grote, K., Tietge, U. J. F., Trautwein, C., Luchtefeld, M., Schmittkamp, C., Heeneman, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148135.08582.97 · Cited by 288
Self-citationRole of NAD(P)H Oxidase in Angiotensin II–Induced JAK/STAT Signaling and Cytokine Induction
Schieffer, B., Luchtefeld, M., Braun, S., Hilfiker, A., Hilfiker-Kleiner, D., & Drexler, H. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1195 · Cited by 273
Self-citationIncreased Oxidative Stress in Experimental Renovascular Hypertension
Lerman, L. O., Nath, K. A., Rodriguez-Porcel, M., Krier, J. D., Schwartz, R. S., Napoli, C., & Romero, J. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.541 · Cited by 271
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Review: IL-6 Transsignaling: The In Vivo Consequences
Jones, S. A., Richards, P. J., Scheller, J., & Rose-John, S. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.241 · Cited by 251
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.065 · Cited by 239
Self-citationInterleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
Ikeda, U., Ikeda, M., Oohara, T., Oguchi, A., Kamitani, T., Tsuruya, Y., & Kano, S. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.5.h1713 · Cited by 225
Interleukin 6: insights to its function in skin by overexpression in transgenic mice.
Turksen, K., Kupper, T., Degenstein, L., Williams, I., & Fuchs, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5068 · Cited by 225
Interleukin-6 Stimulates Circulating Blood-Derived Endothelial Progenitor Cell Angiogenesis in vitro
Fan, Y., Ye, J., Shen, F., Zhu, Y., Yeghiazarians, Y., Zhu, W., Chen, Y., Lawton, M. T., Young, W. L., & Yang, G.-Y. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600509 · Cited by 219
Badache, A., & Hynes, N. E. (2001) · PubMed · Cited by 219
Tubular transport responses to angiotensin
Harris, P. J. F., & Navar, L. G. (1985) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1985.248.5.f621 · Cited by 213
Oxidative Stress in Hypertension
de Champlain, J., Wu, R., Girouard, H., Karas, M., EL Midaoui, A., Laplante, M., & Wu, L. (2004) · Clinical and Experimental Hypertension · doi:10.1081/ceh-200031904 · Cited by 208
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Kallen, K.-J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00325-7 · Cited by 205
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients
Ascer, E., Bertolami, M. C., Venturinelli, M. L., Buccheri, V., Souza, J., Nicolau, J. C., Ramires, J. A. F., & Serrano, C. V. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.003 · Cited by 194
IL-6 Deficiency Protects Against Angiotensin II–Induced Endothelial Dysfunction and Hypertrophy
Schrader, L. I., Kinzenbaw, D. A., Johnson, A. W., Faraci, F. M., & Didion, S. P. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153080 · Cited by 184
Miyaura, C., Onozaki, K., Akiyama, Y., Taniyama, T., Hirano, T., Kishimoto, T., & Suda, T. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81293-6 · Cited by 159
Koike, K., Nakahata, T., Takagi, M., Kobayashi, T., Ishiguro, A., Tsuji, K., Naganuma, K., Okano, A., Akiyama, Y., & Akabane, T. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.3.879 · Cited by 152
Zhou, Z., & Hansson, G. K. (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00559.x · Cited by 149
Klouche, M., Rose‐John, S., Schmiedt, W., & Bhakdi, S. (2000) · Circulation · doi:10.1161/01.cir.101.15.1799 · Cited by 146
Coles, B., Fielding, C., Rose-John, S., Scheller, J., Jones, S. A., & O'Donnell, V. (2007) · American Journal of Pathology · doi:10.2353/ajpath.2007.061078 · Cited by 143
Prediction of Mortality Risk in the Elderly
Störk, S., Feelders, R. A., van den Beld, A. W., Steyerberg, E. W., Savelkoul, H. F. J., Lamberts, S. W. J., Grobbee, D. E., & Bots, M. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.062 · Cited by 139
Recinos, A., LeJeune, W. S., Sun, H., Lee, C. Y., Tieu, B. C., Lu, M., Hou, T., Boldogh, I. R., Tilton, R. G., & Brasier, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.10.013 · Cited by 135
IL-6 Increases Primed Cell Expansion and Survival
Rochman, I., Paul, W. E., & Ben-Sasson, S. Z. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4761 · Cited by 132
Elhage, R., Clamens, S., Besnard, S., Mallat, Z., Tedgui, A., Arnal, J., Maret, A., & Bayard, F. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00682-1 · Cited by 129
JANUS under stress—Role of JAK/STAT signaling pathway in vascular diseases
Grote, K., Luchtefeld, M., & Schieffer, B. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.08.021 · Cited by 128
Self-citationSukovich, D. A., Kauser, K. Z., Shirley, F. D., DelVecchio, V., Halks‐Miller, M., & Rubanyi, G. M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.9.1498 · Cited by 124
Signaling mechanisms through cytokine receptors that share signal transducing receptor components
Taga, T., & Kishimoto, T. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80024-7 · Cited by 122
Molecular and metabolic imaging of atherosclerosis.
Davies, J. R., Rudd, J. H. F., & Weissberg, P. L. (2004) · PubMed · Cited by 119
Angiotensin II induces MMP-2 in a p47phox-dependent manner
Luchtefeld, M., Grote, K., Grothusen, C., Bley, S., Bandlow, N., Selle, T., Strüber, M., Haverich, A., Bavendiek, U., Drexler, H., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.152 · Cited by 119
Self-citationKeidar, S., Heinrich, R., Kaplan, M., Hayek, T., & Aviram, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.095547 · Cited by 118
Sattar, N. A., Murray, H. M., Welsh, P. I., Blauw, G. J., Buckley, B. M., Cobbe, S. M., de Craen, A. J. M., Lowe, G. D. O., Jukema, J. W., Macfarlane, P. W., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000099 · Cited by 114
Reactive Oxygen and NF-κB in VEGF-Induced Migration of Human Vascular Smooth Muscle Cells
Wang, Z., Castresana, M. R., & Newman, W. H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5232 · Cited by 104
Hoffman‐Liebermann, B., & Liebermann, D. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.5.2375 · Cited by 97
Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts
Dasu, M. R. K., Barrow, R. E., Spies, M., & Herndon, D. N. (2003) · Burns · doi:10.1016/s0305-4179(03)00154-2 · Cited by 97
Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK
Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T., & Hirano, T. (1997) · Oncogene · doi:10.1038/sj.onc.1201071 · Cited by 91
Regulation of IL6 gene expression
Sehgal, P. B. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80011-9 · Cited by 91
Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.
Trautwein, C., Böker, K. H. W., & Manns, M. P. (1994) · Gut · doi:10.1136/gut.35.9.1163 · Cited by 88
Interleukin 6 and expression of its receptor on epidermal keratinocytes
Yoshizaki, K., Nishimoto, N., Matsumoto, K., Tagoh, H., Taga, T., Deguchi, Y., Kuritani, T., Hirano, T., Hashimoto, K., Okada, N., et al. (1990) · Cytokine · doi:10.1016/1043-4666(90)90069-6 · Cited by 88
Diagnosis of Atherosclerosis by Imaging
Ibáñez, B., Badimón, J. J., & García, M. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.10.014 · Cited by 85
CD28, IL-2-Independent Costimulatory Pathways for CD8 T Lymphocyte Activation
Sepulveda, H., Cerwenka, A., Morgan, T., & Dutton, R. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1133 · Cited by 83
Nabata, T., Morimoto, S., Koh, E., Shiraishi, T., & Ogihara, T. (1990) · PubMed · Cited by 81
Guo, R., Yang, L., Wang, H., Liu, B., & Wang, L. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2007.12.005 · Cited by 75
NF‐κB is required for TNF‐α‐directed smooth muscle cell migration
Wang, Z., Castresana, M. R., & Newman, W. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03109-x · Cited by 70
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Luchtefeld, M., Schunkert, H., Stoll, M., Selle, T., Lorier, R., Grote, K., Sagebiel, C., Jagavelu, K., Tietge, U. J. F., Assmus, U., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070120 · Cited by 69 · cited 2×
“In line with our experimental data from the animal study we could obtain significant evidence for an association of a genetic variation within the human IL6ST gene and atherosclerosis (92).”
BackgroundResultSelf-citationWisithphrom, K., Murray, P. E., & Windsor, L. J. (2006) · Journal of Endodontics · doi:10.1016/j.joen.2005.10.055 · Cited by 64
Takeda, N., Manabe, I., Shindo, T., Iwata, H., Iimuro, S., Kagechika, H., Shudo, K., & Nagai, R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000214296.94849.1c · Cited by 62
HEDMAN, A. G., Larsson, P. T., Alam, M., Wallén, N. H., Nordlander, R., & Samad, B. A. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.09.004 · Cited by 52
An Essential Role for gp130 in Neointima Formation Following Arterial Injury
Wang, D., Liu, Z., Li, Q., Karpurapu, M., Kundumani‐Sridharan, V., Cao, H., Dronadula, N., Rizvi, F., Bajpai, A. K., Zhang, C., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000261350.61711.9e · Cited by 52
5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation
Luchtefeld, M., Drexler, H., & Schieffer, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01456-6 · Cited by 47
Self-citationAnti-Interleukin-6 Therapy for Crohns Disease
Ito, H. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033391900 · Cited by 41
Trevelyan, J., Brull, D. J., Needham, E. W., Montgomery, H., Morris, A. G., & Mattu, R. K. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.017 · Cited by 41
Fat Stress and Liver Resistance
Ogawa, W., & Kasuga, M. (2008) · Science · doi:10.1126/science.1167571 · Cited by 40
Advances in molecular imaging of atherosclerotic vascular disease
Osborn, E. A., & Jaffer, F. A. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328310fc7e · Cited by 38
Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N. M., Kovach, R. C., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.037 · Cited by 32
Effects of IL6 on B cells in mucosal immune response and inflammation
Fujihashi, K., Kono, Y., & Kiyono, H. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80015-d · Cited by 27
Cited by
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 905
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Kebschull, M., Demmer, R. T., & Papapanou, P. N. (2010) · Journal of Dental Research · doi:10.1177/0022034510375281 · Cited by 429
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
Esenwa, C. C., & Elkind, M. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.125 · Cited by 281
Metadata
- Authors
- Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009
- Volume
- 102
- Issue
- 08
- Pages
- 215-222
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2018239666
- Cited by
- 289
- References
- 123
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.